The Priority Review

Tag

FID 123320

1 story

  1. Clinical trials

    Alcon posts results of Phase 3 FID 123320 study

    The study enrolled 284 participants and was completed with results first posted on ClinicalTrials.gov on November 10, 2026. It assessed the safety and efficacy of FID 123320 Ophthalmic Solution (Apraclonidine HCl 0.125%) versus vehicle for relieving ocular redness in pediatric and adult populations.